Neurology and Neurosurgery - Global Neurology Academy

Episodes 209-224 of 393

Investigating the Prevalence of Comorbidities in MS Clinical Trials
Investigating the Prevalence of Comorbidities in MS Clinical Trials
Global Neurology Academy
Investigating the Prevalence of Comorbidities in MS Clinical Trials
- Ashley Baker, MSN, PMHNP
- Amber Salter, PhD
Assessing Disability in MS Patients with the SNRS and CombiWISE Tools
Assessing Disability in MS Patients with the SNRS and CombiWISE Tools
NeuroFrontiers
Assessing Disability in MS Patients with the SNRS and CombiWISE Tools
- Andrew Wilner, MD, FACP, FAAN
- Dejan Jakimovski, MD, PhD
Disparities in DMT Access: Women with MS Are Less Likely to Receive Treatment
Disparities in DMT Access: Women with MS Are Less Likely to Receive Treatment
NeuroFrontiers
Disparities in DMT Access: Women with MS Are Less Likely to Receive Treatment
- Andrew Wilner, MD, FACP, FAAN
- Victoria Leavitt, PhD
The Alarming Shortage of ADHD Medication and Its Implications on Patients
The Alarming Shortage of ADHD Medication and Its Implications on Patients
NeuroFrontiers
The Alarming Shortage of ADHD Medication and Its Implications on Patients
Practices for Preventing Polypharmacy in Multiple Sclerosis
Practices for Preventing Polypharmacy in Multiple Sclerosis
NeuroFrontiers
Practices for Preventing Polypharmacy in Multiple Sclerosis
- Mary Katherine Cheeley, PharmD, BCPS, CLS, FNLA
- Ahmed Z. Obeidat, MD, PhD
- Lauren Beranek, BS
Understanding the Cellular Basis for Altered Cognition in Schizophrenia
Understanding the Cellular Basis for Altered Cognition in Schizophrenia
NeuroFrontiers
Understanding the Cellular Basis for Altered Cognition in Schizophrenia
- Ashley Baker, MSN, PMHNP
- Samuel Dienel, PhD
From Assessment to Management: Tackling Catatonia in Schizophrenic Patients
From Assessment to Management: Tackling Catatonia in Schizophrenic Patients
NeuroFrontiers
From Assessment to Management: Tackling Catatonia in Schizophrenic Patients
- Ashley Baker, MSN, PMHNP
- Stanley N. Caroff, MD
How Alzheimer's and Lewy Body Pathology Impact CAA Risk Factors
How Alzheimer's and Lewy Body Pathology Impact CAA Risk Factors
NeuroFrontiers
How Alzheimer's and Lewy Body Pathology Impact CAA Risk Factors
- Charles Turck, PharmD, BCPS, BCCCP
- Jagan Pillai, MD, PhD
Advancements in Multiple Sclerosis: Insights from the 2024 ACTRIMS Forum
Advancements in Multiple Sclerosis: Insights from the 2024 ACTRIMS Forum
NeuroFrontiers
Advancements in Multiple Sclerosis: Insights from the 2024 ACTRIMS Forum
Exploring the Latest in MS Cognitive Rehabilitation Strategies
Exploring the Latest in MS Cognitive Rehabilitation Strategies
NeuroFrontiers
Exploring the Latest in MS Cognitive Rehabilitation Strategies
- Nancy Chiaravalloti, PhD
Family Planning Clinical Considerations for Patients with Multiple Sclerosis
Family Planning Clinical Considerations for Patients with Multiple Sclerosis
NeuroFrontiers
Family Planning Clinical Considerations for Patients with Multiple Sclerosis
- Ashley Baker, MSN, PMHNP
- Anna A. Shah, MD
Visionary Insights: Assessing MS-Related Retinal Changes with Adaptive Optics
Visionary Insights: Assessing MS-Related Retinal Changes with Adaptive Optics
NeuroFrontiers
Visionary Insights: Assessing MS-Related Retinal Changes with Adaptive Optics
- Daniel Harrison, MD
Unmet Needs in Rehabilitation Research for Multiple Sclerosis
Unmet Needs in Rehabilitation Research for Multiple Sclerosis
NeuroFrontiers
Unmet Needs in Rehabilitation Research for Multiple Sclerosis
- Robert Motl, PhD
New Guidance on Neurodevelopment Outcomes in Patients with Heart Defects
New Guidance on Neurodevelopment Outcomes in Patients with Heart Defects
Heart Matters
New Guidance on Neurodevelopment Outcomes in Patients with Heart Defects
Telehealth in MS Care: Addressing the Potential for Improvement and Concerns
Telehealth in MS Care: Addressing the Potential for Improvement and Concerns
NeuroFrontiers
Telehealth in MS Care: Addressing the Potential for Improvement and Concerns
- Marisa McGinley, DO
MS Research: Using Epigenetic Clocks and Biomarkers to Assess Biological Aging
MS Research: Using Epigenetic Clocks and Biomarkers to Assess Biological Aging
NeuroFrontiers
MS Research: Using Epigenetic Clocks and Biomarkers to Assess Biological Aging
- Yinan Zhang, MD

14/11